

Cognitive function in the mice lacking osteopontin also improved by about 50%. These mice showed a marked reduction in the build-up of amyloid-beta (Aβ) plaques in the brain-a hallmark of Alzheimer’s disease. The team next engineered the mice so that their microglia couldn’t produce osteopontin. As Alzheimer’s disease progressed, the amount of osteopontin production in the mouse brains doubled to tripled. However, only some CD11c+ microglia produced the potentially toxic protein. These all belonged to a type called CD11c+ microglia. The researchers found that only a small subset of microglia in the brain produced osteopontin. Results were published on February 7, 2023, in the Proceedings of the National Academy of Sciences. They tracked osteopontin production by microglia in the brains. In their new study, the team examined the brains of mice engineered to develop Alzheimer’s disease.

This protein contributes to inflammation and has been linked to neurologic diseases, including Alzheimer’s disease. But the wide variety of microglia, which all have different jobs, has made it difficult to understand whether they play a role in development of the disease.Īn NIH-funded research team has been studying a protein called osteopontin, which can be produced by microglia. Currently, no available treatments can substantially slow progression of the disease, let alone reverse it.Ībnormal functioning of certain immune cells found in the brain, called microglia, is a feature of Alzheimer’s disease. are living with Alzheimer’s disease, a devastating type of dementia, and the number is expected to rise in coming decades. Enter code, hit redeem now, and you’re activated.The activity of microglial cells, shown here near a neuron, may be a potential target for Alzheimer’s disease treatment.Locate “My Account” button in the upper right (next to Buy Now).Create an account on the Astellia Website.During this phase, Astellia is giving away a Razer Laptop! You can earn up to three tickets during this closed beta test for some awesome prizes.The pre-download client will be available on July 25th. This giveaway only gives access to CB2 and is not guaranteed to grant access to future tests. The test begins on July 30th and concludes on August 6th.

